Evidence map›Paper›PMID 25683500›Full record

ArticleAcademic radiology2015

Perfusion CT estimates photosensitizer uptake and biodistribution in a rabbit orthotopic pancreatic cancer model: a pilot study.

Jonathan T Elliott, Kimberley S Samkoe, Jason R Gunn, Errol E Stewart, Timothy B Gardner, Kenneth M Tichauer, Ting-Yim Lee, P Jack Hoopes, Stephen P Pereira, Tayyaba Hasan and 1 more

Abstract read
In one paragraph

Article in Academic radiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Jonathan T ElliottThayer School of Engineering, Dartmouth College, 14 Engineering Drive, Hanover, NH 03755-8000. Electronic address: Jonathan.T.Elliott@dartmouth.edu.
Kimberley S SamkoeThayer School of Engineering, Dartmouth College, 14 Engineering Drive, Hanover, NH 03755-8000; Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire.
Jason R GunnThayer School of Engineering, Dartmouth College, 14 Engineering Drive, Hanover, NH 03755-8000.
Errol E StewartDepartment of Medical Biophysics, Western University, London, Ontario, Canada.
Timothy B GardnerGeisel School of Medicine, Dartmouth College, Hanover, New Hampshire.
Kenneth M TichauerDepartment of Biomedical Engineering, Illinois Institute of Technology, Chicago, Illinois.
Ting-Yim LeeDepartment of Medical Biophysics, Western University, London, Ontario, Canada.
P Jack HoopesThayer School of Engineering, Dartmouth College, 14 Engineering Drive, Hanover, NH 03755-8000; Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire.
Stephen P PereiraInstitute for Liver and Digestive Health, University College London, London, United Kingdom.
Tayyaba HasanWellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts.
Brian W PogueThayer School of Engineering, Dartmouth College, 14 Engineering Drive, Hanover, NH 03755-8000; Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire.
Dartmouth College · USWestern University · CAIllinois Institute of Technology · USMassachusetts General Hospital · USUniversity College London · GB

Funding

Small Molecule Enhancers of Photodynamic Therapy for Skin CancerP01CA084203 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Brian William Pogue · 2001 to 2026
$27.9M
Canadian Institutes of Health ResearchNCI NIH HHS P01 CA084203NCI NIH HHS P01 CA84203
6 · The paper itself

Abstract

RATIONALE AND

objectivesIt was hypothesized that perfusion computed tomography (CT), blood flow (BF), blood volume (BV), and vascular permeability surface area (PS) product parameters would be predictive of therapeutic anticancer agent uptake in pancreatic cancer, facilitating image-guided interpretation of human treatments. The hypothesis was tested in an orthotopic rabbit model of pancreatic cancer, by establishing the model, imaging with endoscopic ultrasound (EUS) and contrast CT, and spatially comparing the perfusion maps to the ex vivo uptake values of the injected photosensitizer, verteporfin. MATERIALS AND

methodsNine New Zealand white rabbits underwent direct pancreas implantation of VX2 tumors, and CT perfusion or EUS was performed 10 days postimplantation. Verteporfin was injected during CT imaging, and the tissue was removed 1 hour postinjection for frozen tissue fluorescence scanning. Region-of-interest comparisons of CT data with ex vivo fluorescence and histopathologic staining were performed.

resultsDynamic contrast-enhanced CT showed enhanced BF, BV, and PS in the tumor rim and decreased BF, BV, and PS in the tumor core. Significant correlations were found between ex vivo verteporfin concentration and each of BF, BV, and PS.

conclusionsThe efficacy of verteporfin delivery in tumors is estimated by perfusion CT, providing a noninvasive method of mapping photosensitizer dose.

Indexed as

AnimalsContrast MediaDisease Models, AnimalIohexolPancreatic NeoplasmsPhotosensitizing AgentsPilot ProjectsPorphyrinsRabbitsTomography, X-Ray ComputedVerteporfinContrast MediaIohexolPhotosensitizing AgentsPorphyrinsVerteporfinCT perfusiondosimetrydrug deliveryPancreatic cancerpharmacokineticsphotodynamic therapy

Identifiers

PMID25683500
PMCPMC4395543
OpenAlexW2212720070

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.